ClinicalTrials HQ

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Recruiting · NCT07226427 · Registry updated 2026-07-06
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian CancerAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingPhase 12026-07-06NCT07226427

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Stemline Therapeutics, Inc.22

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Cancer Research SAAberfoyle ParkAustralia1
Clínica Universidad de NavarraPamplonaSpain12
Clínica Universidad NavarraMadridSpain1
Florida Cancer Specialists & Research InstituteSarasotaUnited States3
Highlands Oncology GroupSpringdaleUnited States62
Hospital Quironsalud MadridPozuelo de AlarcónSpain1
Hospital Universitario 12 de OctubreMadridSpain359
Hospital Universitario Dexeus - Grupo QuironsaludBarcelonaSpain1
Hospital Universitario HM SanchinarroMadridSpain45
ICON Cancer CentreSouth BrisbaneAustralia5
Karmanos Cancer InstituteDetroitUnited States153
Massachusetts General HospitalBostonUnited States1015
Mayo ClinicRochesterUnited States664
NEXT VirginiaFairfaxUnited States83
Yale UniversityNew HavenUnited States29